Arteaga GAC, Castellanos BG, Márquez AG

Language: Spanish
References: 13
Page: 394-399
PDF size: 196.98 Kb.

ABSTRACT

Background: Progestins have been used in the treatment of advanced and metastatic endometrial cancer since the early 1960s. There is evidence that progestins can be used in fertility-preserving treatments in young women diagnosed with well-differentiated clinical stage 1A (EC1A) endometrioid type endometrial carcinoma.
Objective: Describe a fertility preservation treatment in women with primary infertility and EC1A endometrioid type endometrial carcinoma.
Patients and methods: A historical cohort study. We analyzed 6 cases of women under 35 years assisted at the Oncology and Reproductive Medicine Department of the Instituto Nacional de Perinatologia of Mexico who met our inclusion criteria. Five women were treated with 500 mg medroxyprogesterone acetate (MPA) every other day; one woman was treated with 40 mg/day megestrol acetate (MGA). The treatment was continued to a maximum period of 11 months, provided that women gave good response to the treatment. The change in endometrial histology was assessed at four and six months of treatment. The primary endpoint was pathological complete response (CR).
Results. Follow-up time averaged 31 months; 66.6% of women responded to the initial hormone treatment; the remaining 33.4% responded to a second period of progesterone with histology in endometrial biopsy negative for cancer. Average response time was 6.8 months. Two patients had recurrence at an average of 19.5 months. Endometrial routine was performed with a disease-free interval of 15 to 24 months during which assisted reproductive technologies (ART) could be applied. Two patients achieved full-term pregnancy thanks to ART. The remaining patients did not continue with ART on their own initiative.
Conclusions: In young women diagnosed with well-differentiated endometrioid EC1A carcinoma, the fertility-preserving treatment with progestin may be proposed together with strict selection and close monitoring of the patient.

REFERENCES

1. Registro Histopatológico de Neoplasias Malignas en México 2003. Disponible en: http://www.dgepi.salud.gob.mx

2. Sorosky J. Endometrial Cancer. Obstet Gynecol 2008;111:436-447.

3. Signorelli M, Caspani G, Bonazzi C, Chiappa V, Perego P, Mangioni C. Fertility-sparing treatment in young women with endometrial cancer or atypical complex hiperplasia: a prospective single-institution experience of 21 cases. BJOG 2009;116:114-118.

4. Kaku T, Yoshikawa H, Tsuda H et al. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. Cancer Lett 2001;167:39-48.

5. Yahata T, Fujita K, Aoki Y, et al. Longterm conservative therapy for endometrial adenocarcinoma in young women. Hum Reprod 2006;21:1070-1075.

6. Gotlieb WH, Beiner MR, Shalmon B, Korach Y , Segal Y, Zmira N, et al. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer. Obstet Gynecol 2003;102:718-725.

7. Gómez-Pue D, Olaya-Guzmán EJ, Márquez-Acosta G, Jiménez- López J, Durán-Boullosa Esteban, Arteaga-Gómez AC y col. Tratamiento preservador de la fertilidad en adenocarcinoma de endometrio. Ginecol Obstet Mex 2011;79(10):631-636.

8. Chiva L, Lapuente F, Gonzalez-Cortijo L, Carballo N et al. Sparing fertility in young patients with endometrial cancer. Gynecologic Oncology 2008;111:S101-104.

9. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix and endometrium. Int J Gynaecol Obstet 2010;108(2):176.

10. Crissman JD, Azoury RS, Barnes AE. Endometrial cancer in women 40 years of age or younger. Obstet Gynecol 1981; 57:699-704.

11. Yamazawa K, Hirai M, Fujito A, Nishi H et al. Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer. Hum Reprod 2007;22:1953-1958

12. Yamazawa K, Seki K, Matsui H et al. Prognostic factors in young women with endometrial cancer: a report of 20 cases and review of literature. Int J Gynecol Cancer 2000;10:212-222.

13. Lowe MP, Bender D, Sood AK, Davis W, Syrop CH, Sorosky JI. Two successful pregnancies after conservative treatment of endometrial cancer and assisted reproduction. Fertil Steril 2002;77:188-189.